Cellcured
CellCuRex develops regenerative medicine therapies by targeting the cellular microenvironment niche to enable organ partial reprogramming and rejuvenation. The company utilizes patented technology to recreate this niche in-vitro for disease modeling and in-vivo for longevity therapy. They focus on developing efficacious small molecule regenerative cures by modulating signal transduction pathways influencing cell health and aging.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- CellCuRex develops regenerative medicine therapies by targeting the cellular microenvironment niche to enable organ partial reprogramming and rejuvenation. The company utilizes patented technology to recreate this niche in-vitro for disease modeling and in-vivo for longevity therapy. They focus on developing efficacious small molecule regenerative cures by modulating signal transduction pathways influencing cell health and aging.